Literature DB >> 7795157

Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development.

M E Carr1, S L Carr.   

Abstract

During clot retraction, platelets interact with fibrin resulting in marked reduction of clot volume. Altered fibrin structure has been reported to affect clot retraction as measured by serum expression. This study was performed to test whether such altered retraction was the result of increased resistance to network collapse or due to decreased force development by platelets. Altered fibrin structure was documented as variation of fibre mass/length ratios (mu) and shifts in clot elastic modulus. The force developed by platelets during clotting was measured directly. Increasing the fibrinogen concentration led to thinner fibre formation (decreased mu), and a linear increase in gel elastic modulus. Over a fibrinogen concentration range of 100 to 400 mg/dl, force development was minimally affected. Force development and clot elastic modulus increased in a linear fashion with increasing platelet concentration. Increasing the calcium concentration from 5 to 20 mM caused a 160% increase in fibrin fibre size (mu), and a 52% decline in clot modulus. Force developed at 1200 s declined by 17%. At 15 mg/ml, dextran and hydroxyethyl starch (HES) also increased mu, and decreased clot modulus; however, both agents markedly reduced force development. Increasing ionic strength or the addition of IgG decreased mu and increased gel elastic modulus. Force development increased modestly with increased ionic strength, did not change with addition of IgG in saline and declined with addition of IgG in maltose. This study indicates that force development is primarily dependent on platelet function while clot modulus depends on both fibrin structure and platelet function.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795157     DOI: 10.1097/00001721-199502000-00013

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  18 in total

1.  A reconstituted in vitro clot model for evaluating laser thrombolysis.

Authors:  Abram D Janis; Lisa A Buckley; Abby N Nyara; Scott A Prahl; Kenton Gregory
Journal:  J Thromb Thrombolysis       Date:  2002-06       Impact factor: 2.300

2.  A portable blood plasma clot micro-elastometry device based on resonant acoustic spectroscopy.

Authors:  C R Krebs; Ling Li; Alisa S Wolberg; Amy L Oldenburg
Journal:  Rev Sci Instrum       Date:  2015-07       Impact factor: 1.523

3.  Matrices with compliance comparable to that of brain tissue select neuronal over glial growth in mixed cortical cultures.

Authors:  Penelope C Georges; William J Miller; David F Meaney; Evelyn S Sawyer; Paul A Janmey
Journal:  Biophys J       Date:  2006-02-03       Impact factor: 4.033

4.  Compressive mechanical properties of the intraluminal thrombus in abdominal aortic aneurysms and fibrin-based thrombus mimics.

Authors:  John H Ashton; Jonathan P Vande Geest; Bruce R Simon; Darren G Haskett
Journal:  J Biomech       Date:  2008-12-05       Impact factor: 2.712

Review 5.  Microgravity and the implications for wound healing.

Authors:  Ramin Mostofizadeh Farahani; Luisa A DiPietro
Journal:  Int Wound J       Date:  2008-09-19       Impact factor: 3.315

6.  Concentration of fibrin and presence of plasminogen affect proliferation, fibrinolytic activity, and morphology of human fibroblasts and keratinocytes in 3D fibrin constructs.

Authors:  Erik Reinertsen; Michael Skinner; Benjamin Wu; Bill Tawil
Journal:  Tissue Eng Part A       Date:  2014-05-27       Impact factor: 3.845

7.  Structural origins of fibrin clot rheology.

Authors:  E A Ryan; L F Mockros; J W Weisel; L Lorand
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

8.  Applicability and reproducibility of ELSHAFEY technique in different thrombus containing coronary lesions.

Authors:  Wassam El Din Hadad Elshafey
Journal:  Indian Heart J       Date:  2017-05-20

9.  Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin.

Authors:  A Y Mehta; B M Mohammed; E J Martin; D F Brophy; D Gailani; U R Desai
Journal:  J Thromb Haemost       Date:  2016-02-16       Impact factor: 5.824

10.  Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation.

Authors:  Nathan J White; Erika J Martin; Donald F Brophy; Kevin R Ward
Journal:  Resuscitation       Date:  2009-10-24       Impact factor: 5.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.